Bunker Kevin D.

Chief Scientific Officer | Chief Operating Officer

1 company

Excellent

Trades Analyzed

12M Win Rate

88.2%

Avg 3M Return

+9.6%

Avg 12M Return

+42.9%

Bunker Kevin D. is a Chief Scientific Officer at Zentalis Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 35 sells.

Estimated insider holdings value: $3.1M based on current market prices.

Holdings by Company

ZNTLDec 20, 2023

Current Shares834.9K

Value$3.06M

Net Activity-446,005

Bought: 350Sold: 446.4K

Showing 10 filings (page 3)

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Aug 2, 2021	ZNTL Zentalis Pharmaceuticals, Inc.	Chief Operating Officer	Sell	8,420	$51.05	$429,804.91	-10.2%	+61.3%	-41.3%
Jul 7, 2021	ZNTL Zentalis Pharmaceuticals, Inc.	Chief Operating Officer	Sell	24,812	$46.94	$1,164,675.07	-0.3%	+42.9%	-35.9%
Jul 1, 2021	ZNTL Zentalis Pharmaceuticals, Inc.	Chief Operating Officer	Sell	8,420	$51.23	$431,366.83	-7.1%	+19.3%	-43.7%
Jun 1, 2021	ZNTL Zentalis Pharmaceuticals, Inc.	Chief Operating Officer	Sell	8,420	$54.09	$455,441.75	-11.0%	+22.1%	-55.8%
May 3, 2021	ZNTL Zentalis Pharmaceuticals, Inc.	Chief Operating Officer	Sell	8,420	$59.24	$498,783.83	-4.4%	-16.5%	-55.8%
Apr 13, 2021	ZNTL Zentalis Pharmaceuticals, Inc.	Chief Operating Officer	Sell	3,810	$45.00	$171,450.00	-7.0%	+11.3%	-41.0%
Apr 6, 2021	ZNTL Zentalis Pharmaceuticals, Inc.	Chief Operating Officer	Sell	25,211	$43.40	$1,094,031.66	-0.5%	+8.8%	+13.6%
Apr 1, 2021	ZNTL Zentalis Pharmaceuticals, Inc.	Chief Operating Officer	Sell	4,210	$43.45	$182,916.55	-2.5%	+22.8%	+7.5%
Mar 10, 2021	ZNTL Zentalis Pharmaceuticals, Inc.	Chief Operating Officer	Sell	4,720	$45.24	$213,542.24	-7.4%	+23.1%	+2.1%
Mar 3, 2021	ZNTL Zentalis Pharmaceuticals, Inc.	Chief Operating Officer	Sell	3,700	$45.07	$166,747.16	-5.5%	-	-